Celltrio is A Well-Funded Life Science Company With Proven Solutions for Fast Paths to Automation.
Celltrio, Inc. provides automation-based solutions for the life sciences industry with unique, patented or patent-pending intellectual property (IP) - protected solutions in biobanking, cell culturing automation, and more.
The management team is led by two robotics industry and automation veterans, cofounders Charlie Duncheon, CEO, and Dr. Jin-Oh Kim, CTO.
Our solutions are based on IP (including 10 patents) acquired for global exclusivity from our Korean partner who has manufactured and installed over 5000 robots and 11,000 linear modules for the Life Sciences. We are bringing proven solutions to the world market, and are expanding the technology and product line with our US-based engineering team.
We launched our products for global markets in 2018.
You can read our intro announcement here.